Agenus Inc. (AGEN): Price and Financial Metrics

AGEN POWR Grades

• Value is the dimension where AGEN ranks best; there it ranks ahead of 63.82% of US stocks.
• AGEN's strongest trending metric is Quality; it's been moving down over the last 179 days.
• AGEN ranks lowest in Momentum; there it ranks in the 4th percentile.

AGEN Stock Summary

• Equity multiplier, or assets relative to shareholders' equity, comes in at -27.83 for AGENUS INC; that's greater than it is for only 0.77% of US stocks.
• Over the past twelve months, AGEN has reported earnings growth of -478.56%, putting it ahead of only 3.84% of US stocks in our set.
• As for revenue growth, note that AGEN's revenue has grown -66.85% over the past 12 months; that beats the revenue growth of only 2.87% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to AGENUS INC, a group of peers worth examining would be DNN, NVAX, PRQR, DRRX, and PLX.
• AGEN's SEC filings can be seen here. And to visit AGENUS INC's official web site, go to agenusbio.com.

AGEN Valuation Summary

• AGEN's price/sales ratio is 5.8; this is 23.4% higher than that of the median Healthcare stock.
• AGEN's price/sales ratio has moved down 61.4 over the prior 243 months.

Below are key valuation metrics over time for AGEN.

AGEN Growth Metrics

Its 5 year net income to common stockholders growth rate is now at -52.01%.
• Its year over year revenue growth rate is now at 265.6%.
• The 2 year price growth rate now stands at -36.88%.

Over the past 33 months, AGEN's revenue has gone down $60,148,000.

The table below shows AGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	89.9	-150.962	-214.704
2022-06-30	320.082	12.602	18.07
2022-03-31	309.886	0.498	-18.786
2021-12-31	295.665	10.145	-24.137
2021-09-30	306.667	-2.518	3.767
2021-06-30	68.545	-165.517	-225.937

AGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AGEN has a Quality Grade of C, ranking ahead of 55.26% of graded US stocks.
• AGEN's asset turnover comes in at 0.324 -- ranking 139th of 681 Pharmaceutical Products stocks.
• COCP, MTEM, and LGND are the stocks whose asset turnover ratios are most correlated with AGEN.

The table below shows AGEN's key quality metrics over time.